ミッドキャップバイオテクノロジー企業ベンチマークレポート...市場調査レポートについてご紹介

【英文タイトル】PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 9
1.1 List of Tables 15
1.2 List of Figures 16
2 Introduction 18
2.1 Report Scope 18
2.2 Report Catalysts 20
2.3 Upcoming Related Reports 20
2.4 Recently Published Reports 21
2.5 GlobalData’s Benchmarking Methodology 21
2.6 GlobalData 3Q12 Biotech Benchmark Leader: Regeneron 22
2.7 Regeneron Overtook Alexion in 3Q12 as Benchmark Leader 23
3 Financial Management 25
3.1 Competitive Framework 25
3.2 Overview 26
3.2.1 Biotech companies position themselves for revenue growth with higher sales, but will need to focus on cost containment to improve profit margins 26
3.3 Financial Management: Heat Map 28
3.3.1 Regeneron was the financial management leader in 3Q12, posting significantly higher scores across all metrics compared to its peer group 28
3.4 Financial Metrics 29
3.4.1 Revenue 29
3.4.2 Revenue Growth YtY 30
3.4.3 Operating Income 31
3.4.4 Operating Income Growth YtY 32
3.4.5 Operating Margin 33
3.5 Expense Management: Heat Map 34
3.5.1 ViroPharma was the expense management leader in 3Q12 due to manufacturing issues 34
3.6 Expense Metrics 35
3.6.1 R&D Expense as a Percentage of Revenue 35
3.6.2 R&D Spend Growth YtY 36
3.6.3 S,G&A Expenses as a Percentage of Revenue 37
3.6.4 S,G&A Spend Growth YtY 38
3.6.5 Total OpEx as a Percentage of Revenue 39
4 Pipeline Assessment 40
4.1 Overview 40
4.1.1 Despite its high cost, biotech companies are still investing in oncology 40
4.1.2 Big Pharma’s exit from CNS creates an opportunity for smaller players 40
4.2 GlobalData Pipeline Matrix and Competitive Positioning 42
4.2.1 Quadrant Analysis: Best-In-Class Assessment: Regeneron 44
4.2.2 Quadrant Analysis: Challengers Assessment: Jazz 44
4.2.3 Quadrant Analysis: Laggards Assessment: Exelixis 45
4.2.4 Quadrant Analysis: Innovators Assessment: Momenta 45
4.3 Pipeline Development 46
4.4 Clinical Highlights by Company 48
4.4.1 Acorda 48
4.4.2 Alexion 49
4.4.3 Alkermes 49
4.4.4 BioMarin 50
4.4.5 Cubist 51
4.4.6 Exelixis 52
4.4.7 Incyte 53
4.4.8 Jazz 54
4.4.9 Momenta 54
4.4.10 Nektar 55
4.4.11 Onyx 56
4.4.12 Regeneron 57
4.4.13 Seattle 59
4.4.14 United 60
4.4.15 ViroPharma 61
5 Licensing & Acquisition Strategies 62
5.1 Competitive Framework 62
5.2 Overview 63
5.3 M&A Analysis 65
5.3.1 Alkermes Acquisition of Elan Drug Technology Creates Leadership in CNS Therapeutics 65
5.3.2 Jazz Acquisition of EUSA Pharma Expands its Product Line to Include High-Margin Cancer Therapies 66
5.3.3 Alexion Adds to its Ultra-Rare Disease Portfolio through Acquisition 67
5.3.4 Jazz Purchase of Azur Complements its Pipeline in CNS and Women’s Health 68
6 Resource Management Strategies 71
6.1 Competitive Framework 71
6.2 Overview 72
6.3 Operations & Supply Chain 73
6.3.1 Acorda Relocates Corporate HQ to Ardsley Park Life Sciences Campus 73
6.3.2 Cubist Expands Research & Development Facility 73
6.3.3 Jazz Sells Women’s Health Business to Meda 73
6.3.4 Nektar Consolidates Research Assets to its R&D Center in San Francisco, CA 74
6.3.5 Regeneron Expands Greenbush Plant to Support its Antibody Clinic 74
6.3.6 ViroPharma Adds Manufacturing Scale to Cinryze Production to Meet Expected Demand 74
6.4 Resource Management: Heat Map 75
6.4.1 Cubist was the resource management leader in 3Q12, balancing spending & headcount with revenue growth 75
6.5 Firm Utilization Metrics 76
6.5.1 Headcount Growth YtY 76
6.5.2 Revenue per Employee 77
6.5.3 SG&A Expense per SG&A Employee 78
6.5.4 R&D Expense per R&D Employee 79
6.6 Human Capital Leadership Changes 80
6.6.1 Successfully Implement Commercialization Strategies by Retaining Top Talent 80
6.7 Capital Management: Heat Map 81
6.7.1 Momenta was the Capital Management Leader in 3Q12 Keeping its Operating Leverage Lower Compared to its Peer Group 81
6.8 Capital Structure Metrics 82
6.8.1 Debt/Asset Ratio 82
6.8.2 Quick Ratio 83
6.8.3 Cash Ratio 84
6.8.4 Return-on-Investment Ratio 85
6.8.5 Sales/Assets Ratio 86
6.9 Share Offerings & Debt Restructurings 87
6.9.1 Share Repurchases Increase Working Capital and Provide Cash Flow to Reinvest Back into Internal R&D Programs 87
7 Company Drill-Downs & Forecasts 88
7.1 Acorda SWOT & Forecast 88
7.1.1 With Revenue Flattening, Acorda Looks to Extend Ampyra Labeling to Include Additional Indications and More Regions in the EU 88
7.2 Alexion SWOT & Forecast 90
7.2.1 Alexion Supplements its Orphan Drug Strategy with Bolt-on Acquisitions 90
7.3 Alkermes SWOT & Forecast 92
7.3.1 Alkermes is Well Positioned for Strong Revenue Generation as the Company Focuses on Commercializing Internal CNS Drug Candidates 92
7.4 BioMarin SWOT & Forecast 94
7.4.1 BioMarin Will Treat PKU Patients Across Their Entire Lifespan with PEG-PAL for Adults 94
7.5 Cubist SWOT & Forecast 96
7.5.1 Revenue Growth Driven by Higher-than-Expected Sales of Cubicin – Cubist Could Take Share from ViroPharma with CB-315 Drug Candidate 96
7.6 Exelixis SWOT & Forecast 98
7.6.1 Exelixis’ Revenue will Remain Flat Until it Maximizes the Commercial Potential of Cabozantinib for Multiple Oncology Indications 98
7.7 Incyte SWOT & Forecast 100
7.7.1 First-in-Class Jakafi Will Capture a Significant Share of the Myelofibrosis Market 100
7.8 Jazz SWOT & Forecast 102
7.8.1 Jazz’s Revenue Grew through Bolt-on Acquisitions – Higher Margin Cancer Therapies Complement Sales Growth of Xyrem 102
7.9 Momenta SWOT & Forecast 104
7.9.1 While Momenta is Feeling Pressure on its Top-Line, the Company is Poised to Capitalize on Opportunities with Heparin Candidates and Biologics 104
7.10 Nektar SWOT & Forecast 108
7.10.1 Nektar Will Continue to Invest Internally on Novel Cancer Therapies While Sub-licensing its PEGylation Technology to Supplement Revenue Growth 108
7.11 Onyx SWOT & Forecast 112
7.11.1 The Approval of Kyprolis Contributed to Organic Sales for Onyx; However, the Company’s High Cost Structure Erodes any Profitability 112
7.12 Regeneron SWOT & Forecast 115
7.12.1 Regeneron Posts its First Profitable Full-Year in History – Eylea Success Continues to Drive Top-line Growth, Clinical Pipeline is Buzzing 115
7.13 Seattle SWOT & Revenue Forecast 118
7.13.1 As Revenue Peaks, Seattle Expands Adcetris Availability to Outside the US, and Gets Creative with Diagnostic Partnership 118
7.14 United SWOT & Forecast 121
7.14.1 United Will Press Forward with a Plan to Develop an Oral Version of Remodulin, as the PAH Landscape Becomes More Complex 121
7.15 ViroPharma SWOT & Forecast 124
7.15.1 ViroPharma Experienced Significant Erosion from Generic Vancocin; the Company will Now Have to Rely Entirely on Cinryze for Profitability 124
7.16 GlobalData Forecast Summary 127
7.16.1 GlobalData Forecasts vs. Company Reported 3Q12 Results 127
8 Appendix 129
8.1 Research Methodology 129
8.1.1 Coverage 129
8.1.2 Secondary Research 129
8.1.3 Expert Panel Validation 130
8.2 About the Authors 131
8.2.1 Analysts 131
8.3 Director, Healthcare Industry Dynamics 132
8.4 GlobalHead of Healthcare Research & Consulting 132
8.5 About the Industry Dynamics Team 133
8.6 GlobalData 134
8.7 Contact Us 134
8.8 Disclosure Information 134
8.9 Disclaimer 135


【レポート販売概要】

■ タイトル:ミッドキャップバイオテクノロジー企業ベンチマークレポート
■ 英文:PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs
■ 発行日:2013年1月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160307
■ 調査対象地域:グローバル
  • バーチャル発電所の世界市場予測(~2021)
    The global virtual power plant market is projected to grow at a CAGR of 29.68% from 2016 to 2021, to reach a market size of USD 709.2 Million by 2021. This growth is attributed to the increasing penetration of smart grid technologies as well as increase in residential energy storage system has given rise to the virtual power plant market. An aggregated fleet of distributed energy resources would p …
  • アドバンスト・アナリティクスの世界市場2016-2020
    About Advanced Analytics Advanced analytics is the practice that helps in the extraction of information from existing or historical data, which helps in understanding the growth pattern and predicting the trends or future of the organization. Analytics uses what-if scenarios to predict possible risks involved in the future. Technavio’s analysts forecast the global advanced analytics market to grow …
  • ソーシャルゲーム市場参入と成功戦略分析2013(Social Gaming Market Entry and Success Strategy Analysis 2013)
    The significant rise of social networks has created a springboard for the social gaming segment of the entertainment industry. Gaming is becoming increasingly compelling thanks to various enhancements such as the addition of socially playable and sharable features within games, which have gradually become common characteristics. While generally a lucrative segment, the industry has its own challen …
  • Wassenburg Medical Devices B.V.:市場シェア分析
    Wassenburg Medical Devices B.V. Market Share Analysis Summary GlobalData’s new report, “Wassenburg Medical Devices B.V. Market Share Analysis” provides in-depth information on Wassenburg Medical Devices B.V.’s market position in the different medical equipment markets it operates in. The report provides Wassenburg Medical Devices B.V. market share information in one key market category – Endoscopi …
  • 4WDトランスファケース用アクチュエータの世界市場
    The automotive transfer case actuator is a type of motor that operates through electric current, hydraulic fluid, or pneumatic pressure, and converts that energy into motion. The automotive transfer case actuator market is projected to grow at a CAGR of 14.38% from 2016 to 2021. Major players in the market include Magna International (Canada), Aisin Seki (Japan), Borg Warner (U.S.), and JTEKT (Jap …
  • ポリフッ化ビニリデン(PVDF)のグローバル市場動向(~2019)
    The report covers the global PVDF market. It further divides the market on the basis of end user industry, applications, geography. The market data for these types is given with respect to volume (metric tons) and value ($thousand). The global market value of PVDF was estimated to be $596,009.6 thousand in 2012 and is projected to grow with a CAGR of about 7.4% from 2014 to 2019. The data mentione …
  • プログラマブルオートメーションコントローラーの世界市場展望2017-20276
    According to Stratistics MRC, the Global Programmable Automation Control Market expected to grow at a CAGR of 4.3% during the forecast period. Some of the key factors fueling the market are increasing demand for the high-performance and powerful functionality controller for satisfying the complex control requirements of the industries. However, demand for customization of products and gradual shif …
  • 粉末コーティング剤のインド市場
    The India powder coatings market accounted for revenue of $896.7 million in 2017 and is anticipated to generate revenue of $1,508.2 million by 2025. This market is projected to grow at a CAGR of 6.6% from 2018 to 2025.Powder coating is a dry finishing process in which fine particles of paint are electrostatically charged and sprayed onto a workpiece. Powder coatings possess various properties such …
  • Cenovus Energy, Inc.:石油・ガスバリューチェーン分析レポート2013
    Cenovus Energy, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Cenovus Energy, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Cenovus Energy, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report exam …
  • ドイツの感染症検査市場2014
    This report provides an overview of the German infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment. Table of ContentsBusiness EnvironmentMarket Structure  Market Size, Growth, and Major Suppliers' Market SharesList of Tables            &n …
  • ニューモシスチス感染症(Pneumocystis Infection):治療薬開発パイプライン動向(2015年上半期版)
    Pneumocystis Infection - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Pneumocystis Infection - Pipeline Review, H1 2015’, provides an overview of the Pneumocystis Infection’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Pneumocystis Infection, complete with comparative analysis at various stages, therapeutics assessment by dr …
  • 中小企業向けオンライン融資プラットフォームの世界市場2016-2020
    About Online Financing Platform Online financing is a method of debt financing where different individuals can lend and borrow money using an online platform. Such systems eliminate any involvement of middlemen or banking institutions. The loans provided by the lender help the lender to generate income in the form of interest. On the other hand, the borrowers have easy access to financing, which m …
  • Epic Energy:石油・ガスバリューチェーン分析レポート2013
    Epic Energy Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Epic Energy" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Epic Energy”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business …
  • Pengrowth Energy Corporation:石油・ガスの開発・生産動向及びコスト分析– Q4, 2012
    Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Pengrowth Energy Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an es …
  • Orthostatic Hypotension:グローバル臨床試験レビューH1, 2014
    Orthostatic Hypotension Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, “Orthostatic Hypotension Global Clinical Trials Review, H1, 2014" provides data on the Orthostatic Hypotension clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Orthostatic Hypotension. It includes an overview of the trial numbers …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。